Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
The system measures biological and environmental changes, and detects contact between the mask and the wearer’s skin.
Skills learned in the classroom are applied toward health and sanitation projects.
A system for monitoring motion and muscle engagement could aid the elderly and athletes during unsupervised physical rehabilitation for injuries or impaired mobility.
Greater availability of de-identified patient health data would enable better treatments and diagnostics, the researchers say.
“AI for endometriosis? If only there were data!”
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
A machine-learning method finds patterns of health decline in ALS, informing future clinical trial designs and mechanism discovery. The technique also extends to Alzheimer’s and Parkinson’s.
By continuously monitoring a patient’s gait speed, the system can assess the condition’s severity between visits to the doctor’s office.
An interdisciplinary team is developing a mobile health platform that uses AI to detect infection in Cesarean section wounds.
Mel King Community Fellows from MIT's Community Innovators Lab meet in Berlin to examine the German elder care model.
In a recent MISTI course, students engaged on collaborative solutions to climate, health care, and economic development in the Middle East.
An MIT-developed device with the appearance of a Wi-Fi router uses a neural network to discern the presence and severity of one of the fastest-growing neurological diseases in the world.
MIT alumni-founded WalkWise uses a motion-detecting device for walkers to allow family members and care professionals to monitor adults with mobility challenges.
The MIT researcher and former professor discusses how Covid-19 and the influx of virtual technologies created a new medical ecosystem that needs more synchronized oversight.